Darren SissonsFresenius SE FRE.DEPAST TOP PICKJul 26, 2019

(A Top Pick Jul 31/18, Down 34%) Sold it 6 months after picking the stock. Had a big drop in the forth quarter and sold it in a risk management point of view. It's the global leader in kidney diagnosis treatment so the business isn't going away. Still likes the company. If it was to drop a little bit further he would consider buying it back. A good company, just had an unfortunate earnings report during Q4 in December, a really bad timing, if they had it in January we wouldn't have seen that down.